Hermans, Raine (contributor); Kulvik, Martti (contributor) - 2005
positive
towards marketing approval of 13 designated orphan drugs.
Proteins and molecules are constructed in a living cell … example, as pre-marketing appraisals of the
economic impact of a new drug, or retrospectively, for example, as research …;
and only 21.5 percent of drugs that begin phase 1 human trials are eventually approved for
marketing (DiMasi, Hansen et …